Supplements vergleichen

Off-label use mirrors approved dosing (10 mg once daily) under a clinician. A prescription drug; not an approved longevity regimen.

Morning

Orale Tablette (Dapagliflozin)

284 mg (300 mg inclisiran sodium) by subcutaneous injection administered by a healthcare professional on day 1, again at day 90 (month 3), then every 6 months thereafter. A prescription drug; this is the approved regimen, not a self-directed supplement protocol.

Any time

Vorgefüllte subkutane Injektion (Inclisiran 284 mg)

• Type 1 diabetes (ketoacidosis risk)
• Severe renal impairment per label / dialysis
• History of recurrent diabetic ketoacidosis

• Diuretics
• Insulin / sulfonylureas

• Known hypersensitivity to inclisiran or excipients
• Not a substitute for a clinician's evaluation — prescription drug only

• Statins / ezetimibe
• PCSK9 monoclonal antibodies (evolocumab / alirocumab)